Patients with multivessel or left main coronary artery disease in optimal physical and mental health fare much better with CABG surgery than PCI over long-term follow-up, an analysis of the SYNTAX ...

John Ross may be Australia's longest surviving double bypass patient. Here's how has the cardiac operation has evolved over ...

Analysis of more than 55,000 CABG patients documents worse outcomes and burgeoning costs for patients with diabetes, according to reports in The Journal of Thoracic and Cardiovascular Surgery Summary: ...

Relying entirely on arteries as a source for grafts in CABG appears to impart better survival for patients irrespective of age, according to a new analysis of registry data from Australia and New ...

The relative benefits of coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) continue to be actively debated and analyzed. A recent meta-analysis of individual data from 7 ...

Real-World Analysis Shows Statistically Significant Reduction in Severe Bleeding and Transfusion Needs in CABG Patients on the Blood Thinner, Ticagrelor, with CytoSorbents Therapy Presented by ...

A new study that monitors patients who received "on-pump" or "off-pump" coronary artery bypass grafting (CABG) over a 10-year period reveals that outcomes between the two forms of heart bypass surgery ...

After undergoing coronary artery bypass grafting (CABG), a patient was sent home on clopidogrel (Plavix) but not aspirin. When he presented to the emergency department with acute coronary syndrome ...

Valdecoxib is not approved for use in the treatment of postoperative pain of any type. Valdecoxib is a cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drug (NSAID) that is indicated in the ...

Please provide your email address to receive an email when new articles are posted on . Approximately one in five patients who underwent CABG also had high Lp(a). High Lp(a) at baseline was associated ...